The World Vaccine Congress is one of the largest conferences dedicated to vaccines, covering a wide range of topics related to vaccine science and research, to manufacturing and policy, and more. USP is proud to serve as a gold sponsor for this year’s meeting.
USP participation
Innovation in vaccine manufacturing: Biodefense & Preparedness Workshop
Monday, April 1, 10 - 11 am EST
Room 201
In this discussion during the Biodefense & Preparedness workshop, the panel will highlight progress on new technologies in medical product development, government incentives, including in biotech, and global collaborations. Specifically, USP will discuss facilitating adoption and regulatory pathways relative to new manufacturing platforms.
Speaker: Diane McCarthy, Senior Director, Biologics Science & Standards, USP
Leveraging the rollout of COVID-19 vaccines to strengthen pharmacovigilance systems in Africa
Wednesday, April 3, 10:10 am EST
Room 204C
This session will highlight tools and methods used in evaluating adverse events following immunization (AEFI), which is especially important in low- and middle-income countries (LMICs) where monitoring and collecting of non-specific effects and genetic background or prior pathogen exposure may impact the safety profile of vaccines. The session will also explore the use of novel methods for collection and analysis of vaccine safety data in LMICs through various case studies and discuss advancing public private partnerships for greater patient awareness of vaccine safety.
Speakers: Laura Martin, Vaccines Program Director, Global Health Technical Programs, USP Comfort Ogar, Senior Pharmacovigilance Manager, Global Health Technical Programs, USP
Evolving vaccine standards to support quality throughout the product lifecycle: from raw materials to drug product
Wednesday, April 3, 12:40 pm EST
Room 209AB TBD
This session will spotlight USP's significant contributions to global vaccine quality, including setting and upholding rigorous standards that guide manufacturers and regulatory bodies alike, as well as ongoing efforts in developing new and forthcoming reference standards and analytical reference materials crucial for vaccine quality testing. The session will also highlight facilitating harmonization and standardization across the industry to bolster vaccine quality and efficacy on a global scale.
Speaker: Sarita Acharya, Principal Scientist, Global Biologics, USP
Download the full program and register: https://www.terrapinn.com/wvcdc
Not able to join virtually? Follow us @USPGlobalHealth for updates. #WVCDC
Get the latest updates on global health projects. Sign up for our newsletter.